organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91³Ô¹Ï Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
91³Ô¹Ï Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Journal of Alzheimers Disease & Parkinsonism have been cited by esteemed scholars and scientists all around the world. Journal of Alzheimers Disease & Parkinsonism has got h-index 25, which means every article in Journal of Alzheimers Disease & Parkinsonism has got 25 average citations.
Following are the list of articles that have cited the articles published in Journal of Alzheimers Disease & Parkinsonism.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Total published articles |
26 | 33 | 60 | 35 | 45 | 44 | 107 | 89 |
Conference proceedings |
0 | 33 | 0 | 0 | 82 | 213 | 118 | 158 |
Citations received as per Google Scholar, other indexing platforms and portals |
123 | 389 | 489 | 425 | 374 | 263 | 237 | 253 |
Journal total citations count | 4334 |
Journal impact factor | 2.04 |
Journal 5 years impact factor | 3.14 |
Journal cite score | 10.01 |
Journal h-index | 25 |
Journal h-index since 2019 | 22 |
![]() |
Nanotoxicity and Risk Assessment |
| | | |
![]() |
Modulation of the microbiota-gut-brain axis by bioactive food, prebiotics, and probiotics decelerates the course of Alzheimer's disease |
| | | |
![]() |
Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer’s Disease |
| | | |
![]() |
Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer’s Disease in Mice |
| | | |
![]() |
Roles of Gut Microbiota in Pathogenesis of Alzheimer’s Disease and Therapeutic Effects of Chinese Medicine |
| | | |
![]() |
Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine |
| | | |
![]() |
Crosstalk between Gut and Brain in Alzheimer’s Disease: The Role of Gut Microbiota Modulation Strategies |
| | | |
![]() |
Dysbiosis and Alzheimer’s Disease: A Role for Chronic Stress? |
| | | |
![]() |
Alternative Anti-Infective / Anti-Inflammatory Therapeutic Options for Fighting Alzheimer’s Disease |
| | | |
![]() |
The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease? |
| | | |
![]() |
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame? |
| | | |
![]() |
Facilitation of Gastrointestinal (GI) Tract Microbiome-Derived Lipopolysaccharide (LPS) Entry Into Human Neurons by Amyloid Beta-42 (A?42) Peptide |
| | | |
![]() |
Cell surface amyloid proteins of microorganisms: structure, properties and significance in medicine |
| | | |
![]() |
The role of the gut microbiome in mediating neurotoxic outcomes to PCB exposure |
| | | |
![]() |
A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders |
| | | |
![]() |
Age-related cerebral small vessel disease and inflammaging |
| | | |
![]() |
Functional amyloids: interrelationship with other amyloids and therapeutic assessment to treat neurodegenerative diseases |
| | | |
![]() |
Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer’s Disease |
| | | |
![]() |
Down-Regulation of Essential Synaptic Components by GI-Tract Microbiome-Derived Lipopolysaccharide (LPS) in LPS-Treated Human Neuronal-Glial (HNG) Cells in Primary Culture: Relevance to Alzheimer’s Disease (AD) |
| | | |
![]() |
Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC |
| | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, 91³Ô¹Ï Journals